3 ms·
Why would FDA do that? Obesity is the biggest public health disaster in US. They should make it as cheap as ibuprofen.
by feverzsj 1y ago
Why would FDA do that? Obesity is the biggest public health disaster in US. They should make it as cheap as ibuprofen.
- TylerE 1y agoBecause it’s under patent. There was a temporary allowance for compounding it due to sustained manufacturer shortages but that is in the process of expiring.
- digianarchist 1y agoWasn’t GLP-1 discovered in 1984?
- TylerE 1y agoNot the newer ones that have lower risks of lifetime digestive issues.
- mac-mc 1y agoAs far as we know.
- raincom 1y agoThe first generation drug Exenatide's patent was filed in 1992, but got approved in 2005. The latest one is Tirzepatide, a dual agonist, approved in 2022. Expect soon for Retaglutide, a triple agnonist, in the market.
- apwell23 1y agohopefully to protect my investment in lily
- wyager 1y agoDo you want them to keep spending money on drug R&D to solve all the other problems that still exist?
- feverzsj 1y agoNo one says companies should lose money. The government can cover the price for everyone just like they did for covid vaccines. Considering obesity adds between $147 billion and $210 billion to annual U.S. health-care expenses[0], it would cost much less. [0]: https://theweek.com/articles/870872/americas-deadly-obesity-epidemic https://theweek.com/articles/870872/americas-deadly-obesity-...
- oezi 1y agoMy mathematical intuition says this isn't really much considering US annual GDP is 27 trillion (27,000 billions) USD. So less than 1% of GDP. Your linked article says: Obesity adds between $147 billion and $210 billion to annual U.S. health-care expenses, increasing an average adult's medical costs by 42 percent — an estimated $200,000 over a lifetime. Since annual GDP per person in the US is roughly 80k USD and average life expectancy is also roughly 80 so roughly 6.4m USD GDP per person lifetime. 200,000 USD over 6.4m would imply over 3% of GDP, which seems more reasonable.
- feverzsj 1y agoGDP isn't actual income. It's just a number.
- oezi 1y agoSure, but gross labor share of GDP is 60% in the US (salaried employees earn 60% of GDP in total) so it doesn't change the consideration that much. The US is spending roughly 15% of the GDP on health. If 1% of GDP is due to obesity then this is 'just' 1/15th of the overall health spending. If 3% of GDP is due to obesity then this is 20% (3/15th) of the overall health cost in the US.
- morkalork 1y agoCareful, if you start framing the problem like that you might end up with socialized healthcare!
- HDThoreaun 1y agoIt isn’t a choice. Compounding is only legal when there is a federal shortage of the drug. When the shortage ends so does compounding. If the fda declares a shortage when there isn’t one they get sued.